Theravance Biopharma, Inc.

TBPHNASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
16.29 USD
↘ 0.08 (0.49%)AT CLOSE (11:59 AM EDT)
16.29
↘ 0.01 (0.03%)
POST MARKET (AS OF 05:14 PM EDT)
Post Market
AS OF 05:14 PM EDT
16.29
↘ 0.01 (0.03%)
🔴Market: CLOSED
Open?$16.44
High?$16.65
Low?$16.28
Prev. Close?$16.37
Volume?242.8K
Avg. Volume?357.0K
VWAP?$16.41
Rel. Volume?0.68x
Bid / Ask
Bid?$16.28 × 2.0K
Ask?$16.96 × 100
Spread?$0.68
Midpoint?$16.62
Valuation & Ratios
Market Cap?839.8M
Shares Out?51.6M
Float?46.9M
Float %?92.6%
P/E Ratio?7.33
P/B Ratio?2.89
EPS?$2.22
Dividend?0.00%
Ex-Dividend?N/A

Theravance Biopharma, Inc. (TBPH) trades at $16.29 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (39.4%) and a bearish Death Cross on the long-term moving averages. Valuation metrics place TBPH at a fair price relative to peers.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
Themes
Biotech - Drug Development›Neuroscience & CNSBiotech - Drug Development›Rare Disease Therapeutics
Employees
90
Market Cap
839.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.theravance.com
Listed
2014-05-16
Address
UGLAND HOUSE, SOUTH CHURCH STREET
GEORGE TOWN, GRAND CAYMAN, CA KY1-1104
Phone: 650-808-6000
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
17
Momentum?
50
Short Sent.?
28
Piotroski F-Score?3/9Weak
Altman Z-Score?1.35Distress
Confidence?69%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?10.64%High
Short Interest?5.0M
Days to Cover?14.8
Free Float46.9M
Avg Daily Volume337.7K
Settlement Date2026-05-15
Financial Health
Current Ratio?6.47Strong
Quick Ratio?6.47Strong
Cash Ratio?4.46Strong
Debt/Equity?0.01Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
72/100
P/E?
Peers
100
S&P
97
7.3CHEAP▾
P/B?
Peers
100
S&P
58
2.89CHEAP▾
P/S?
Peers
100
S&P
14
7.65HIGH▾
P/FCF?
Peers
100
S&P
97
3.1CHEAP▾
EV/EBITDA?
Peers
100
S&P
3
84.3HIGH▾
EV/Sales?
Peers
100
S&P
36
5.05FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
87
39.4%STRONG▾
ROA?
Peers
50
S&P
97
24.3%STRONG▾
Cash Flow & Enterprise
FCF?$268.7M
Enterprise Value?$554.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist